Teichoic acid biosynthesis as an antibiotic target

Current Opinion in Microbiology

Volumn 16, Issue 5, 2013, Pages 531-537

  Pasquina, Lincoln W ^a   Santa Maria, John P ^a   Walker, Suzanne ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHITOSAN; EPICATECHIN GALLATE; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; TEICHOIC ACID; TICLOPIDINE; TUNICAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL VIABILITY; BIOSYNTHESIS; CARBOHYDRATE SYNTHESIS; DELETION MUTANT; DRUG TARGETING; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; REVIEW; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOSYNTHETIC PATHWAYS; DRUG DISCOVERY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 84887626427     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.06.014     Document Type: Review

References (53)

1. Nannini E., Murray B.E., Arias C.A. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 2010, 10:516-521.
2. Johnson A.P. Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 2011, 66(Suppl 4):iv43-iv48.
3. Neuhaus F.C., Baddiley J. A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev 2003, 67:686-723.
4. Weidenmaier C., Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 2008, 6:276-287.
5. Swoboda J.G., Campbell J., Meredith T.C., Walker S. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem 2010, 11:35-45.
6. Reichmann N.T., Gründling A. Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. FEMS Microbiol Lett 2011, 319:97-105.
7. Xia G., Maier L., Sanchez-Carballo P., Li M., Otto M., Holst O., Peschel A. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J Biol Chem 2010, 285:13405-13415.
8. Xia G., Kohler T., Peschel A. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int J Med Microbiol 2010, 300:148-154.
9. Brown S., Xia G., Luhachack L.G., Campbell J., Meredith T.C., Chen C., Winstel V., Gekeler C., Irazoqui J.E., Peschel A., et al. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A 2012, 109:18909-18914.
10. Gründling A., Schneewind O. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc Natl Acad Sci U S A 2007, 104:8478-8483.
11. Gründling A., Schneewind O. Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J Bact 2007, 189:2521-2530.
12. Schirner K., Marles-Wright J., Lewis R.J., Errington J. Distinct and essential morphogenic functions for wall- and lipo-teichoic acids in Bacillus subtilis. EMBO J 2009, 28:830-842.
13. Lu D., Wörmann M.E., Zhang X., Schneewind O., Gründling A., Freemont P.S. Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS. Proc Natl Acad Sci U S A 2009, 106:1584-1589.
14. Iwasaki H., Shimada A., Yokoyama K., Ito E. Structure and glycosylation of lipoteichoic acids in Bacillus strains. J Bact 1989, 171:424-429.
15. Dengler V., Meier P.S., Heusser R., Kupferschmied P., Fazekas J., Friebe S., Staufer S.B., Majcherczyk P.A., Moreillon P., Berger-Bächi B., et al. Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response. FEMS Microbiol Lett 2012, 333:109-120.
16. Brown S., Zhang Y.H., Walker S. A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem Biol 2008, 15:12-21.
17. Brown S., Meredith T., Swoboda J., Walker S. Staphylococcus aureus and Bacillus subtilis W23 make polyribitol wall teichoic acids using different enzymatic pathways. Chem Biol 2010, 17:1101-1110.
18. Kawai Y., Marles-Wright J., Cleverley R.M., Emmins R., Ishikawa S., Heinz N., Bui N.K., Hoyland C.N., Ogasawara N., Lewis R.J., et al. A widespread family of bacterial cell wall assembly proteins. EMBO J 2011, 30:4931-4941.
19. May J.J., Finking R., Wiegeshoff F., Weber T.T., Bandur N., Koert U., Marahiel M.A. Inhibition of the d-alanine:d-alanyl carrier protein ligase from Bacillus subtilis increases the bacterium's susceptibility to antibiotics that target the cell wall. FEBS J 2005, 272:2993-3003.
20. Oku Y., Kurokawa K., Matsuo M., Yamada S., Lee B., Sekimizu K. Pleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of Staphylococcus aureus cells. J Bact 2009, 191:141-151.
21. Corrigan R.M., Abbott J.C., Burhenne H., Kaever V., Gründling A. c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog 2011, 7:e1002217.
22. Campbell J., Singh A.K., Santa Maria J.P., Kim Y., Brown S., Swoboda J., Mylonakis E., Wilkinson B.J., Walker S. Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol 2011, 6:106-116.
23. Atilano M.L., Yates J., Glittenberg M., Filipe S.R., Ligoxygakis P. Wall teichoic acids of Staphylococcus aureus limit recognition by the drosophila peptidoglycan recognition protein-SA to promote pathogenicity. PLoS Pathog 2011, 7:e1002421.
24. Smith E.J., Corrigan R.M., van der Sluis T., Gründling A., Speziale P., Geoghegan J.A., Foster T.J. The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid. Mol Microbiol 2012, 83:789-804.
25. Peschel A., Otto M., Jack R.W., Kolbacher H., Jung G., Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999, 274:8405-8410.
26. Kristian S.A., Lauth X., Nizet V., Goetz F., Neumeister B., Peschel A., Landmann R. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis 2003, 188:414-423.
27. Weidenmaier C., Kokai-Kun J.F., Kristian S.A., Chanturiya T., Kalbacher H., Gross M., Nicholson G., Neumeister B., Mond J.J., Peschel A. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004, 10:243-245.
28. Wang H., Gill C.J., Lee S.H., Mann P., Zuck P., Meredith T.C., Margulo N., She X., Kales S., Liang L., et al. Discovery of wall teichoic acid inhibitors as potential anti-MRSA beta-lactam combination agents. Chem Biol 2013, 20:272-284.
29. D'Elia M.A., Henderson J.A., Beveridge T.J., Heinrichs D.E., Brown E.D. The N-acetylmannosamine transferase catalyzes the first committed step of teichoic acid assembly in Bacillus subtilis and Staphylococcus aureus. J Bact 2009, 191:4030-4034.
30. Atilano M.L., Pereira P.M., Yates J., Reed P., Veiga H., Pinho M.G., Filipe S.R. Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci U S A 2010, 107:18991-18996.
31. Qamar A., Golemi-Kotra D. Dual roles of FmtA in Staphylococcus aureus cell wall biosynthesis and autolysis. Antimicrob Agents Chemother 2012, 56:3797-3805.
32. Farha M.A., Leung A., Sewell E.W., D'Elia M.A., Allison S.E., Ejim L., Pereira P.D., Pinho M.G., Wright G.D., Brown E.D. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to beta-lactams. ACS Chem Biol 2013, 8:226-233.
33. Schlag M., Biswas R., Krismer B., Kohler T., Zoll S., Yu W., Schwarz H., Peschel A., Götz F. Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol 2010, 75:864-873.
34. Weidenmaier C., Peschel A., Xiong Y.Q., Kristinan S.A., Dietz K., Yeaman M.R., Bayer A.S. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 2005, 191:1771-1777.
35. Koyama N., Inokoshi J., Tomoda H. Anti-infectious agents against MRSA. Molecules 2012, 18:204-224.
36. D'Elia M.A., Pereira M.P., Chung Y.S., Zhao W., Chau A., Kenney T.J., Sulavik M.C., Black T.A., Brown E.D. Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J Bact 2006, 188:4183-4189.
37. Meredith T.C., Swoboda J.G., Walker S. Late-stage polyribitol phosphate wall teichoic acid biosynthesis in Staphylococcus aureus. J Bact 2008, 190:3046-3056.
38. Campbell J., Singh A.K., Swoboda J.G., Gilmore M.S., Wilkinson B.J., Walker S. An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus. Antimicrob Agents Chemother 2012, 56:1810-1820.
39. Swoboda J.G., Meredith T.C., Campbell J., Brown S., Suzuki T., Bollenbach T., Malhowski A.J., Kishony R., Gilmore M.S., Walker S. Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem Biol 2009, 4:875-883.
40. Lee K., Campbell J., Swoboda J.G., Cuny G.D., Walker S. Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg Med Chem Lett 2010, 20:1767-1770.
41. Biswas R., Martinez R.E., Göhring N., Schlag M., Josten M., Xia G., Hegler F., Gekeler C., Gleske A., Götz F., et al. Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS ONE 2012, 7:e41415.
42. Shiratsuchi A., Shimizu K., Watanabe I., Hashimoto Y., Kurokawa K., Razanajotovo I.M., Park K.H., Park H.K., Lee B.L., Sekimizu K., Nakanishi Y. Auxiliary role for d-alanylated wall teichoic acid in Toll-like receptor 2-mediated survival of Staphylococcus aureus in macrophages. Immunology 2010, 129:268-277.
43. Gotz F. Staphylococcus and biofilms. Mol Microbiol 2002, 43:1367-1378.
44. Collins L.V., Kristian S.A., Weidenmaier C., Faigle M., van Kessel K.P.M., van Strijp J.A.G., Götz F., Neumeister B., Peschel A. Staphylococcus aureus strains lacking d-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis 2002, 186:214-219.
45. Falord M., Karimova G., Hiron A., Msadek T. GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2012, 56:1047-1058.
46. Richter S.G., Elli D., Kim H.K., Hendrickx A.P.A., Sorg J.A., Schneewind O., Missiakas D. Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria. Proc Natl Acad Sci U S A 2013, 110:3531-3536.
47. Schirner K., Stone L.K., Walker S. ABC transporters required for export of wall teichoic acids do not discriminate between different main chain polymers. ACS Chem Biol 2011, 6:407-412.
48. Raafat D., von Bargen K., Haas A., Sahl H.G. Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol 2008, 74:3764-3773.
49. Raafat D., Sahl H.G. Chitosan and its antimicrobial potential-a critical literature survey. Microb Biotechnol 2009, 2:186-201.
50. Stapleton P.D., Shah S., Ehlert K., Hara Y., Taylor P.W. The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus. Microbiology 2007, 153:2093-2103.
51. Bernal P., Zloh M., Taylor P.W. Disruption of d-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the β-lactam resistance modifier (-)-epicatechin gallate. J Antimicrob Chemother 2009, 63:1156-1162.
52. Bernal P., Lemaire S., Pinho M.G., Mobashery S., Hinds J., Taylor P.W. Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2. J Biol Chem 2010, 285:24055-24065.
53. Anderson J.C., McCarthy R.A., Paulin S., Taylor P.W. Anti-staphylococcal activity and beta-lactam resistance attenuating capacity of structural analogues of (-)-epicatechin gallate. Bioorg Med Chem Lett 2011, 21:6996-7000.